Inclusion Criteria:  The participant has a body mass index (BMI) ≥18 and ≤30 kilograms (kg)/square meter (m^2) at the screening visit. The participant has a weight of ≥60 kg at the screening visit and baseline visit. The participant has a waist circumference ≤94 centimeters (cm) at the screening visit.  Exclusion Criteria:  The participant has taken disallowed medication <2 weeks prior to the first dose of study drug or <5 half-lives prior to the screening visit for any medication taken. The participant has received a COVID-19 vaccination within the last 30 days before receiving first dose of study drug. The participant has or has had any clinically significant immunological, cardiovascular, respiratory, metabolic, renal, hepatic, gastrointestinal, endocrinological, haematological, dermatological, venereal, neurological, or psychiatric disease or other major disorder.  Note: Other inclusion and exclusion criteria may apply.